Offshoring Ethical Analysis

Upon reading The Ethical of Offshoring Clinical Trials, three factors were driving pharmaceutical companies to host clinical drug trials overseas. The factors were lower cost, willingly to participate in trials, and a larger pool of patients. People that are overseas are more than likely to participate in trials since they would rather have an expensive medicine than to not have any at all. While the likeliness of participating in trials, it also increases the larger pool of patients. The larger the pool of patients, the more accurate the statistics are. Furthermore, the U.S. pharmaceutical companies have discovered the qualities of their stats from overseas countries are the same, but they can get those same results for a lower price. The regulations that are in place to oversee the professional and ethical management of these trials will be several countries have developed laws against pharmaceutical companies to prevent their citizens from getting injured. Those several countries have laws that prevent pharmaceutical companies to use their citizens in highly experimental drug trials. Countries such as China and Russia have specifically developed laws to prevent the concerns over illegal trafficking human organs. These also have
This will be less stressful to figure out. Another suggestion would be more rigorous laws should be developed so the citizens of the country participating in the trials are not being injured. If possible, the individuals who are being exposed in the trials should have some kind of benefit besides the medical benefit for participating in the trial. With some changes, it would not only benefit the pharmaceutical company, but it would benefit the participating patient as